The 2022–2023 mpox outbreak triggered vaccination efforts using smallpox vaccines that
were approved for mpox, including modified vaccinia Ankara (MVA; JYNNEOS), which is a …

Background Vaccination against mpox (formerly known as monkeypox), an infectious
disease caused by the monkeypox virus (MPXV), is needed to prevent outbreaks and …

Monkeypox (mpox) virus belongs to the same family as variola virus causing smallpox.
Usually spreading through skin-to-skin contact with the mpox-infected and causing rashes …

Current unprecedented mpox outbreaks in non-endemic regions represent a global public
health concern. Although two live-attenuated vaccinia virus (VACV)-based vaccines have …

The recent global outbreak of the monkeypox (mpox) virus in humans was declared a public
health emergency by the World Health Organization in July 2022. The smallpox and mpox …

Background Although the mpox global health emergency caused by mpox virus (MPXV)
clade IIb. 1 has ended, mpox cases are still reported due to low vaccination coverage and …

Vaccination is one of the tools used against the 2022 outbreak of mpox (formerly known as
monkeypox), considered a Public Health Emergency of International Concern by WHO until …

Introduction Before the global mpox outbreak which began in 2022, the real-world vaccine
effectiveness (VE) of mpox vaccines was unknown. We quantified the VE in the global …

Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022.
Following historic success of smallpox vaccination with vaccinia virus (VACV)-based …

According to the World Health Organization, 83,339 laboratory-confirmed cases, including
72 deaths, of mpox (formerly known as monkeypox), have been reported from 110 locations …